ClinConnect ClinConnect Logo
Search / Trial NCT06643169

The Effect of Home Based Fall Prevention Program on Older Adults at High Risk of Falling

Launched by ISTANBUL UNIVERSITY · Oct 14, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

High Fall Risk Elderly Fall Prevention Home Based

ClinConnect Summary

This clinical trial is studying a home-based program designed to help older adults who are at high risk of falling. The goal is to see if this program, led by nurses, can reduce the number of falls, improve balance, lower the fear of falling, and enhance overall quality of life for participants. Researchers will also look at how many people end up in the hospital due to falls and whether their homes are safe for them.

To participate in this study, individuals need to be at least 65 years old and assessed as having a high risk of falling. This is determined using a simple self-assessment tool. Participants will also have a physical therapist evaluate them to ensure it's safe for them to exercise. Those who have had recent heart surgery, certain health conditions like low blood pressure when standing, or regular exercise routines will not be eligible. If someone joins the study, they can expect support and guidance on exercises and safety measures to help them stay active and safe at home.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Individuals aged 65 years and over with a high risk of falling (Those who score four and above on the Falls Risk Self-Assessment Scale will be determined as having a high risk of falling).
  • To be examined by a physical therapist and to obtain consent that there is no harm in exercising (They will be referred to Bartın State Hospital and evaluated by a physical therapy specialist physician),
  • Without a diagnosis of orthostatic hypotension,
  • Elderly individuals who volunteered to participate in the study were identified.
  • Exclusion Criteria:
  • Cardiovascular surgery in the last one year
  • Diagnosis of orthostatic hypotension
  • Having a neurological or neurodegenerative disease (such as Parkinson's dementia)
  • Older people who exercise regularly,

About Istanbul University

Istanbul University, a leading institution in Turkey, is dedicated to advancing healthcare through rigorous clinical research and education. Renowned for its commitment to scientific excellence and innovation, the university sponsors clinical trials that aim to enhance medical knowledge and improve patient outcomes. With a diverse team of researchers and healthcare professionals, Istanbul University fosters collaboration across disciplines to explore new therapeutic interventions and contribute to global health advancements. Its robust infrastructure and ethical standards ensure the highest quality in clinical trial management, making it a key player in the field of medical research.

Locations

Bartın, , Turkey

Patients applied

0 patients applied

Trial Officials

Selda Secginli, Prof.Dr.

Study Director

selda.secginli@atlas.edu.tr

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported